ArticleAIDS and behavior2025
Preferences for HIV Pre-exposure Prophylaxis among Gay, Bisexual, and Men Who Have Sex with Men in China: a Discrete Choice Experiment.
Article in AIDS and behavior, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Moderating Role of Condom-Use Inertia on the Association Between Status Quo Bias and Pre-Exposure Prophylaxis Resistance Intention Among Chinese Men Who Have Sex With Men: Cross-Sectional Study.JMIR public health and surveillance · 2026Article
- How Status Quo Bias Shapes Willingness, Uptake, and Adherence to PrEP Among Chinese MSM: A Behavioral Economics Perspective.Infectious diseases and therapy · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Pre-exposure prophylaxis (PrEP) is highly effective in preventing HIV in gay, bisexual, and other men who have sex with men (GBMSM). This study investigates PrEP usage and preferences among Chinese GBMSM and how key attributes influence their choices using a discrete choice experiment (DCE). Six PrEP attributes were evaluated: dosing frequency, dispensing venue, side effects, effectiveness, follow-up frequency, and extra services. From January to November 2022, a face-to-face survey was conducted among 1186 GBMSM in Xi'an, China. Multi- and mixed-logit models assessed preferences and heterogeneity by demographics. Latent class analysis examined unobserved preference patterns, and scenario analysis explored how changes in attributes affect PrEP acceptance. Among 995 valid participants (mean age 34 ± 9 years), 20.5% had ever used PrEP. The most influential attribute was dosing frequency, followed by side effects and follow-up frequency. Participants preferred on-demand PrEP, private dispensing venues, minimal side effects, at least 60% effectiveness, follow-up every 3 months, and comprehensive STI testing. Preferences varied by age, education, and income. Latent class analysis indicated 57.04% of participants preferred on-demand PrEP, STD/social health clinics, very low-risk kidney complications, 80% effectiveness, 3-month follow-up, and no extra services. Scenario analysis showed on-demand PrEP and 80% effectiveness would increase acceptance by 73.6% and 43.2%, respectively, compared to daily oral PrEP and 30% effectiveness. Conversely, switching from daily oral pills to bi-monthly injections decreased acceptance by 48.2%. Dosing frequency is the most influential attribute for HIV PrEP among Chinese GBMSM. Preferences vary by demographics, and reduced dosing and improved effectiveness may substantially boost uptake.
Indexed as
Identifiers
40465041What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.